Restoring miR-34a led to inhibition of proliferation and invasiveness by targeting a network of pro-tumor genes such as c-Met, Bcl-2, Cyclin D1, and PD-L1 in preclinical HCC models [105]. The gene discussed is CD274; the disease is hepatocellular carcinoma.